Attend the 11th Digital Pharma East conference this October 3–6, 2017 in Philadelphia, PA to learn from more than 130 senior-level, life science marketing experts. This is the industry’s largest and leading event for life science marketers looking for inspiration, insights from experts and the chance to network with over 800 conference attendees. Join us to learn how to enable end-to-end digitization of your enterprise, elevate your marketing strategies and improve customer centricity.
Click the event buttons below to learn more or to register today.
Join 150+ senior-level clinical quality, compliance and operations professionals from pharma, biotech and device companies of all sizes, to discuss strategies for ensuring clinical trial integrity by effectively assessing, optimizing and managing the quality of vendors and sites.
Taking place October 11–13, 2017 this is the annual gathering for clinical quality, operations, management and audit professionals to engage and candidly share their experiences, struggles, obstacles, and achievements when working with varying clinical partners, including CROs and investigator sites. Be sure to register today!
Join us at the 4th Technology Transfer for Biologics conference — the only educational event in the U.S. to focus on the project, facility, and partnership management skills needed to maintain biologics quality at every step of process transfer and scale-up — taking place October 16–17, 2017 in Boston.
This year’s show features an all-new lineup of case studies to help you guarantee the reliability of your supply chain to U.S. and emerging markets, while also accelerating late-stage biologics development and exploring advancements in single-use technologies and commercialization software.
If you haven’t secured your seat at this year’s conference, register today!
With the increasing use of Data Monitoring Committees (DMC) during randomized clinical trials, sponsors and stakeholders are now facing new challenges. Their roles have changed over the years and are involved in increasingly varied types of trials. Unclear roles and responsibilities can add to confusion between DMC and trial stakeholders.
The 2017 DMC Optimization Summit, taking place October 19–20 in Philadelphia, PA, will bring together clinical health professionals to address the current landscape of DMC use and conduct, while clarifying the purpose of using a DMC. Our speakers will discuss preparing statistical reports, charter planning, regulatory reporting, and much more! Attendees will gain a better understanding of how to form committees of qualified members who communicate in a way that is understood by all stakeholders and increases the quality of trial oversight.
The 4th Clinical Trials Phase I & Phase IIA Summit, taking place October 19–20 in Philadelphia, will provide an overview of the most recent trends, regulatory updates, and operational challenges in early-phase clinical trials. The agenda features industry professionals with decades of valuable experience, speaking on the most pressing topics.
Join your peers as they discuss the best ways to improve strategic partnerships towards increasing safety standards and advancing early-phase studies.
Don’t miss out on this opportunity to learn from and network with your colleagues from Bristol-Myers Squibb, Eisai, Celgene, Janssen R&D, Merck, Sanofi and other organizations.
ExL’s first annual Value-Based Strategies for Reimbursement and Formulary Success is taking place November 6–7 in Bethesda, MD. This event will pioneer the conversation on the transition from price-centric to value-based formularies. Life science and healthcare insurance executives will provide attendees with education in proving value, instead of managing pricing of drugs coming onto the market. This event will arm professionals with the skills and methods to prepare for formulary success before FDA approval through regulatory, medical affairs, R&D, and market access collaboration. The event will also provide strategies for those who do not gain formulary access initially so that attendees walk away with an auxiliary strategy to ultimately gain formulary approval through post-approval market access expansion tactics using real-world evidence and HEOR.
Don’t miss out on this opportunity to learn from and network with your colleagues from Merck, Johnson & Johnson, Pfizer and more!
The 4th Adverse Events Reporting and Safety Strategies Summit, taking place December 4–5 in Philadelphia, will offer in-depth analysis of benefit-risk assessments, real-world data, risk management plans, signal detection, periodic reporting and solicited/unsolicited reports.
This participant-driven summit illustrates why it is the event of choice for AE and drug safety for insightful thought leaders, seasoned professionals and savvy leaders from the realm of PV.
If you haven’t registered for the 4th Adverse Events Reporting and Safety Strategies Summit, secure your seat today!
Kelly Willenberg LLC is a full service research compliance organization serving clients on improving operations. She employs technologies to improve operational aspects of compliance based on client needs. She assists in the implementation of billing compliance programs, offers training seminars, builds coverage analysis and helps with process improvement. She can also assist with process improvement, quality assurance and assessing vulnerabilities in all aspects of research compliance.
FiercePharma is a digital media publication, reporting and delivering daily news and objective analysis for business professionals in global industries. FiercePharma offers broad coverage serving a wide range of specific functional interests, including manufacturing regulation, financial management, quality control and production methods; shareholder pressure and speed-to-market strategies; sales and marketing access to physicians and navigating payer rules; the impact of pricing and partnerships on the pipeline; and the influence of big data, executive moves and social media on it all.
MAPS is the premier non-profit global society of Medical Affairs professionals across a spectrum of fields, experience, and locales. With our non-profit status, MAPS is able to reinvest all revenue back into the society, which ensures our ability to create valuable programs and resources that support the Medical Affairs community. MAPS is transforming the Medical Affairs industry to increase its value to companies and, ultimately, benefit patients and consumers.
JUST ANNOUNCED: Cannabis Partnerships Congress, March 2018 in San Francisco
ExL Events is excited to announce the Cannabis Partnerships Congress, taking place March 12–13, 2018 in San Francisco, CA! The Cannabis Congress is an educational forum designed to bring all stakeholders involved in the cannabis-based scientific, medicinal, governmental, and product development to fortify the therapies in a collaborative environment.
In addition to conferences, ExL Events also provides industry-related content through a variety of social platforms. Be sure to follow the profiles that fit your topics of interest to gain access to the latest content and industry news.
Fill out our form to receive topic-specific conference emails as well as updates.